174 related articles for article (PubMed ID: 38441970)
1. CD93 maintains endothelial barrier function and limits metastatic dissemination.
Vemuri K; de Alves Pereira B; Fuenzalida P; Subashi Y; Barbera S; van Hooren L; Hedlund M; Pontén F; Lindskog C; Olsson AK; Lugano R; Dimberg A
JCI Insight; 2024 Mar; 9(7):. PubMed ID: 38441970
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
[TBL] [Abstract][Full Text] [Related]
3. CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin.
Lugano R; Vemuri K; Barbera S; Orlandini M; Dejana E; Claesson-Welsh L; Dimberg A
FASEB J; 2023 Apr; 37(4):e22894. PubMed ID: 36961390
[TBL] [Abstract][Full Text] [Related]
4. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
5. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
6. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
7. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
Li X; Padhan N; Sjöström EO; Roche FP; Testini C; Honkura N; Sáinz-Jaspeado M; Gordon E; Bentley K; Philippides A; Tolmachev V; Dejana E; Stan RV; Vestweber D; Ballmer-Hofer K; Betsholtz C; Pietras K; Jansson L; Claesson-Welsh L
Nat Commun; 2016 Mar; 7():11017. PubMed ID: 27005951
[TBL] [Abstract][Full Text] [Related]
8. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
Tae N; Lee S; Kim O; Park J; Na S; Lee JH
Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling.
Balaji Ragunathrao VA; Anwar M; Akhter MZ; Chavez A; Mao Y; Natarajan V; Lakshmikanthan S; Chrzanowska-Wodnicka M; Dudek AZ; Claesson-Welsh L; Kitajewski JK; Wary KK; Malik AB; Mehta D
Cell Rep; 2019 Dec; 29(11):3472-3487.e4. PubMed ID: 31825830
[TBL] [Abstract][Full Text] [Related]
10. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
11. Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch.
Tian Y; Gawlak G; O'Donnell JJ; Birukova AA; Birukov KG
J Biol Chem; 2016 May; 291(19):10032-45. PubMed ID: 26884340
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
[TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.
Kao YC; Jiang SJ; Pan WA; Wang KC; Chen PK; Wei HJ; Chen WS; Chang BI; Shi GY; Wu HL
PLoS One; 2012; 7(12):e51647. PubMed ID: 23272129
[TBL] [Abstract][Full Text] [Related]
14. Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells.
Barbera S; Raucci L; Tassone G; Tinti L; Prischi F; Santucci A; Mongiat M; Tosi GM; Galvagni F; Dimberg A; Pozzi C; Orlandini M
Int J Biol Macromol; 2023 Jan; 224():453-464. PubMed ID: 36265539
[TBL] [Abstract][Full Text] [Related]
15. Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.
da Silva RG; Tavora B; Robinson SD; Reynolds LE; Szekeres C; Lamar J; Batista S; Kostourou V; Germain MA; Reynolds AR; Jones DT; Watson AR; Jones JL; Harris A; Hart IR; Iruela-Arispe ML; Dipersio CM; Kreidberg JA; Hodivala-Dilke KM
Am J Pathol; 2010 Sep; 177(3):1534-48. PubMed ID: 20639457
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
[TBL] [Abstract][Full Text] [Related]
17. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell biology: an update. 5th International Symposium on the Biology of Endothelial Cells.
Morawietz H; Breier G
Thromb Haemost; 2006 Jun; 95(6):1025-30. PubMed ID: 16732383
[TBL] [Abstract][Full Text] [Related]
19. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
